Miniatura

Fitxers

571194.pdf (439.74 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2010-04

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/120395

Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1038/jid.2009

Resum

Mycosis fungoide (MF) patients who develop tumors or extracutaneous involvement usually have a poor prognosis with no curative therapy available so far. In the present European Organization for Research and Treatment of Cancer (EORTC) multicenter study, the genomic profile of 41 skin biopsies from tumor stage MF (MFt) was analyzed using a high-resolution oligo-array comparative genomic hybridization platform. Seventy-six percent of cases showed genomic aberrations. The most common imbalances were gains of 7q33.3q35 followed by 17q21.1, 8q24.21, 9q34qter, and 10p14 and losses of 9p21.3 followed by 9q31.2, 17p13.1, 13q14.11, 6q21.3, 10p11.22, 16q23.2, and 16q24.3. Three specific chromosomal regions, 9p21.3, 8q24.21, and 10q26qter, were defined as prognostic markers showing a significant correlation with overall survival (OS) (P=0.042, 0.017, and 0.022, respectively). Moreover, we have established two MFt genomic subgroups distinguishing a stable group (0-5 DNA aberrations) and an unstable group (>5 DNA aberrations), showing that the genomic unstable group had a shorter OS (P=0.05). We therefore conclude that specific chromosomal abnormalities, such as gains of 8q24.21 (MYC) and losses of 9p21.3 (CDKN2A, CDKN2B, and MTAP) and 10q26qter (MGMT and EBF3) may have an important role in prognosis. In addition, we describe the MFt genomic instability profile, which, to our knowledge, has not been reported earlier.

Matèries

Oligonucleòtids, Genòmica, Micosi, Tumors, Marcadors genètics

Matèries (anglès)

Oligonucleotides, Genomics, Mycosis, Tumors, Genetic markers

Citació

Col·leccions

Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Medicina)

Citació

SALGADO, Rocío, SERVITJE BEDATE, Octavio, GALLARDO, F. (fernando), VERMEER, Maarten h., ORTIZ ROMERO, Pablo luis, KARPOVA, Maria b., ZIPSER, Marie c., MUNIESA MONTSERRAT, Cristina, GARCIA-MURET, Maria p., ESTRACH PANELLA, Ma. teresa (maría teresa), SALIDO GALEOTE, Marta, SÁNCHEZ SCHMIDT, Júlia, HERRERA, Marta, ROMAGOSA, Vicenç, SUELA, Javier, FERREIRA, Bibiana i., CIGUDOSA, Juan cruz, BARRANCO, Carlos, SERRANO, Sergi, DUMMER, Reinhard, TENSEN, Cornelis p., SOLÉ RISTOL, Francesc, PUJOL, Ramon m., ESPINET SOLÀ, Blanca. Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides. _Journal of Investigative Dermatology_. 2010. Vol. 130, núm. 4, pàgs. 1126-1135. [consulta: 27 de gener de 2026]. ISSN: 0022-202X. [Disponible a: https://hdl.handle.net/2445/120395]

Exportar metadades

JSON - METS

Compartir registre